204 related articles for article (PubMed ID: 23916293)
1. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.
Spitsin S; Stevens KE; Douglas SD
J Neurol Sci; 2013 Nov; 334(1-2):18-23. PubMed ID: 23916293
[TBL] [Abstract][Full Text] [Related]
2. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals.
Douglas SD; Lynch KG; Lai JP
J Neurol Sci; 2008 Sep; 272(1-2):174-7. PubMed ID: 18572194
[TBL] [Abstract][Full Text] [Related]
5. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
Lai JP; Lai S; Tuluc F; Tansky MF; Kilpatrick LE; Leeman SE; Douglas SD
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12605-10. PubMed ID: 18713853
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin 1 receptor isoforms and the control of innate immunity.
Tuluc F; Lai JP; Kilpatrick LE; Evans DL; Douglas SD
Trends Immunol; 2009 Jun; 30(6):271-6. PubMed ID: 19427266
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
Koh YH; Tamizhselvi R; Bhatia M
J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
[TBL] [Abstract][Full Text] [Related]
8. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
9. The neuropeptide substance P is a critical mediator of burn-induced acute lung injury.
Sio SW; Puthia MK; Lu J; Moochhala S; Bhatia M
J Immunol; 2008 Jun; 180(12):8333-41. PubMed ID: 18523300
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation.
Zhan M; Zheng W; Jiang Q; Zhao Z; Wang Z; Wang J; Zhang H; He S
Cell Biol Toxicol; 2017 Aug; 33(4):389-405. PubMed ID: 28154998
[TBL] [Abstract][Full Text] [Related]
11. Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.
Spitsin S; Pappa V; Douglas SD
J Leukoc Biol; 2018 Jan; ():. PubMed ID: 29345372
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
13. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
Koh YH; Moochhala S; Bhatia M
J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
[TBL] [Abstract][Full Text] [Related]
14. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L
Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486
[TBL] [Abstract][Full Text] [Related]
15. Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression.
Li Y; Douglas SD; Pleasure DE; Lai J; Guo C; Bannerman P; Williams M; Ho W
J Neurosci Res; 2003 Feb; 71(4):559-66. PubMed ID: 12548712
[TBL] [Abstract][Full Text] [Related]
16. Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P.
Azma T; Sugimoto Y; Kinoshita H; Ito T; Tsukamoto M; Hoshijima H; Nakao M; Kikuchi H
J Thromb Thrombolysis; 2012 May; 33(4):329-37. PubMed ID: 22057425
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase C in caerulein induced expression of substance P and neurokinin-1-receptors in murine pancreatic acinar cells.
Koh YH; Tamizhselvi R; Moochhala S; Bian JS; Bhatia M
J Cell Mol Med; 2011 Oct; 15(10):2139-49. PubMed ID: 20973912
[TBL] [Abstract][Full Text] [Related]
18. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
[TBL] [Abstract][Full Text] [Related]
19. HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P.
Tuluc F; Meshki J; Spitsin S; Douglas SD
J Leukoc Biol; 2014 Jul; 96(1):143-50. PubMed ID: 24577568
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi
Suthiram J; Pieters A; Mohamed Moosa Z; Zeevaart JR; Sathekge MM; Ebenhan T; Anderson RC; Newton CL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
